Rodent models of colitis and intestinal fistula have shown BPC-157 reduces inflammation and promotes mucosal healing via oral route
Antibodies targeting IL1- have also shown mixed, although more positive effects, particularly in reducing HbA1c with IL1- antagonism [206], with recent evidence suggesting that combined TNF-alpha and IL1- blockade may be most effective for glycemic control [207]
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), tirzepatide produces synergistic effects like increased insulin production and release, which gives it an edge over strict GLP-1 receptor agonist such as semaglutide (Ozempic)
Accessed 3 Nov 2025
Frhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM
This is where I actually clean my skin without leaving residue